background: Human spermatogenesis is regulated by complex networks, and estrogens are recognized as one of the significant regulators of spermatogenesis. We tested the associations between variants of estrogen-related genes and semen parameters.
Introduction
Between 2 and 12% of couples worldwide are affected by reduced fertility, and male factors account for approximately half of the infertility in these couples (Bhasin et al., 1994) . The causes of male infertility could be categorized as pretesticular, testicular and post-testicular (de Kretser, 1997) . Despite significant improvement in the diagnostic work-up of male infertility, the reasons for infertility remain unclear in roughly 50% of men with testicular defects (Krausz and Giachini, 2007) .
Since early 1990, a growing body of evidence has implied that the quality of human semen is deteriorating worldwide. Numerous studies also suggested that environmental endocrine disrupters are a major culprit in this trend toward impaired spermatogenesis (Cotton, 1994; O'Donnell et al., 2001; Sharpe and Irvine, 2004) . Human spermatogenesis is regulated by a highly orchestrated † The first two authors contributed equally to this study. coordination of developmental processes under complex endocrine, autocrine and paracrine control in the testis. Estrogens are recognized as one of the significant regulators of spermatogenesis (Sharpe, 1998; Akingbemi, 2005; Carreau and Hess, 2010; .
Steroid hormones exert their cellular effects through genomic and non-genomic pathways (Baldi et al., 2009) . Estrogens are carried by sex hormone-binding globulin (SHBG) to the target tissue. In the target tissue, the genomic effect of estrogens is mediated by estrogen receptors (ER-a or ER-b) (Kato et al., 2000; Mahato et al., 2001) . Estrogen receptor-a knockout (ERaKO) and double knockout (ERa/bKO) male mice were infertile since puberty, and the testicular histology showed atrophy of the testes, dysmorphogenesis of seminiferous tubules and impaired spermatogenesis (Gould et al., 2007) . Expression studies in prepubertal human testis suggested that estrogen may modulate the preservation of an adequate pool of precursor Leidyg cells and germ cells (Berensztein et al., 2006) . Genetic variants of ERs or aromatase have been detected in cases of idiopathic azoospermia. Among these cases, some showed total depletion of germ cells in the testes while other affected males had only slightly reduced sperm motility (Suzuki et al., 2002; Lazaros et al., 2010) . Although a number of studies have shown associations between common variants of estrogen-related genes and male infertility, these studies were by and large focused on specific genes (Fritsche et al., 1998; Carreau et al., 2002; Suzuki et al., 2002; Ahn et al., 2009) . In addition, the subjects in previous studies were often infertile men, but no details of reproductive phenotype were specified (Lazaros et al., 2010) .
Although the reference values and thresholds for semen parameters established by the World Health Organization (WHO) are routinely used to evaluate the male partners of infertile couples, there is extensive overlap for all measurements between fertile and subfertile men (Guzick et al., 2001 ). In addition, many infertile men present with abnormal semen parameters with multiple abnormalities, e.g. a combination of oligozoospermia and teratozoospermia or a combination of oligozoospermia and asthenozoospermia. Therefore, the application of 'reference' values to predict fertility has obvious limitations (Lewis, 2007; Cooper et al., 2010) . During the past decade, the abundance of genetic markers has made it possible to identify genetic loci, which are responsible for the variation of continuous traits (Farrall, 2004; McCarthy et al., 2008) . To dissect the roles of specific genetic pathways in spermatogenesis, it would be more appropriate to take semen parameters as quantitative traits instead of using the arbitrary binary diagnoses of normal and abnormal semen parameters.
Recently, we conducted a case -control study that reported the polygenic effect of estrogen-related genes on sperm concentration in a cohort of 303 men in the Han Taiwanese . We found that common polymorphisms of estrogen-related genes jointly confer susceptibility to impaired sperm production. In the present study using quantitative trait analysis, we went further to test how estrogen-related genes are involved in regulating all the three major semen parameters (sperm concentration, sperm motility and morphology) in a larger cohort of male samples. We found that common polymorphisms of estrogen-related genes mainly affect sperm concentration and motility. Our findings support the concept that endogenous or xenobiotic estrogen and estrogen-related genes are mainly involved in regulating sperm concentration and motility (Aquila et al., 2003; Lambard et al., 2004; Fraser et al., 2006) .
Materials and Methods

Subjects
From January 2002 to June 2006, 677 men with known semen parameters were enrolled into the study. The fertile men were recruited from volunteers who had fathered at least one child within 2 years without assisted reproduction technologies. The control subjects (n ¼ 210) included the 120 controls described in Su et al. (2010) . Male partners of infertile couples who visited our infertility special clinics routinely underwent semen analysis. Cases with abnormal semen parameters were then recruited into the study (n ¼ 467), including 183 who were described previously . To avoid deviation in quantitative trait analysis, azoospermic men were excluded. All enrollees belonged to Han Taiwanese, the major ethnic group in Taiwan (more than 95% of the country's population). The study was approved by the National Science Council of Taiwan and the Institutional Review Board of National Cheng Kung University Medical Centre. The detailed enrollment and evaluation procedures were described in our previous study . Briefly, signed informed consent was obtained from all enrollees. All subjects underwent comprehensive characterization, including a detailed history, physical examination, at least two semen analyses and karyotyping and molecular tests for Y-chromosomal deletions (Teng et al., 2006 (Teng et al., , 2007 . All enrolled subjects had a normal karyotype and intact Y chromosome. Subjects with any identifiable cause of male infertility, including varicocele, hypogonadotrophic hypogonadism, toxic habits (tobacco, alcohol or drug use), occupational exposure, previous treatment (immuno-therapy, cancer therapy or hormone therapy), unilateral orchidectomy, vasectomy and chronic genital infections were excluded from the study.
Semen parameters
For semen analysis, the ejaculate was obtained by masturbation after a minimum 48 h of sexual abstinence. Semen analysis was performed according to the protocol recommended by the WHO using a modified Neubauer chamber (WHO, 1999) . The record of sperm concentration, percentage of normal motile sperm and morphology was based on at least two separate semen analyses performed by two independent laboratory technicians. The sperm morphology score is shown in Supplementary data, Table SI. The mean values of the semen parameters acquired from two separate analyses were used as quantitative traits. The sperm concentration and motility were quantified in all 677 individuals, whereas the morphology of sperm was measured in 623 (92%) individuals. The interobserver coefficient of variation was low (9.3%) for the three major semen parameters (sperm concentration, motility and morphology). Abnormal semen parameters included oligozoospermia (sperm concentration ,20 × 10 6 /ml), asthenozoospermia (sperm motility ,50%) and teratozoospermia (percentage of sperm with normal morphology ,30%).
Genotyping
Genomic DNA was extracted from peripheral blood samples using a Puregene DNA isolation kit (Gentra Systems, Inc.) Polymorphic sites of estrogen-related genes were selected if significant associations were reported between the loci and any estrogen-related diseases, including breast cancer, osteoporosis, endometriosis and various benign or malignant tumors. The estrogen-related genes genotyped in this study included estrogen receptors (ER-a, ER-b), estrogen synthesizing/transporting genes (cytochrome p450, family 1, subfamily A, polypeptide 1 CYP19A1, 17-beta-dehydrogenase 1, HSD17B1 and SHBG) and genes encoding metabolizing enzyme (CYP1A1, CYP1B1, catechol-O-methyltransferase COMT, glutathione S-transferase Mu 1 GSTM1, glutathione S-transferase theta 1 GSTT1). Fifteen single nucleotide polymorphisms (SNPs) and two deletion polymorphisms were chosen out of the 10 genes. Of these SNPs, rs1801132 (ER-a), rs4986938, rs1256049 (ER-b), rs605059 (HSD17B1) and rs10046 (CYP19A1) are tag SNPs in the HapMap database.
SNP sites were detected by primer extension analysis using end-point TaqMan assays (Applied Biosystems, Warrington, UK) in 96-well arrays, and genotypes were subsequently read on a 7900 Sequence Detector (Applied Biosystems). The control samples for TaqMan assay had been confirmed by direct genomic DNA sequence analysis using an automatic sequencer (ABI 377, Applied Biosystems/PE). The null mutations of GSTM1 and GSTT1 were determined by using multiplex PCR, with the b-globin gene as a positive control for amplification as described previously (Finotti et al., 2009; Wu et al., 2008) . In total, 17 markers were genotyped in 673 individuals. The overall genotyping rate was high (99.52%) in our samples, although a few failed: six individuals failed genotyping for marker rs2676530 in HSD17B1, five failed for GSTM1 and four failed for GSTT1. All participants (n ¼ 677) were retained in the analyses.
Statistics
Quantitative trait analyses for log-transformed sperm concentration, motility and morphology were conducted using PLINK (Purcell, http://pngu. mgh.harvard.edu/~purcell/plink/) for the selected polymorphic loci. At the single marker level, in addition to allelic tests, we employed genotypic tests, including additive, recessive and dominance models, and a 2 degree-of-freedom joint test for additive and dominance effects. We used regression-based models, which were implemented in PLINK to calculate the significance level for each marker with quantitative traits. Data were presented as mean + SD unless otherwise specified. Hardy -Weinberg equilibrium (HWE) was also tested via the PLINK system, with a threshold of 0.05.
The underlying true genetic models for quantitative sperm parameters are unknown and the four applied genotypic tests are exploratory in nature. We are aware of the possibility of inflated type I errors related to multiple testing of our results. Two strategies were adopted to reduce this potential problem, including 10 000 permutation tests to confirm the significance level in different genetic models and a more stringent threshold for claiming significance. In general, the permutation P-values were in concordance with the nominal P-values, thus, nominal P-values were displayed in the tables. In addition, a nominal P-value of ,0.01 was set as a threshold for statistical significance.
For each of the sperm parameters, if multiple loci showed associations, a joint analysis would then be performed for associated markers to obtain the 'loci-dosage' effects (i.e. whether lower sperm count or decreased sperm motility was observed with increasing numbers of risk loci). The mean t-test was used to test for trend for the quantitative sperm parameters with increasing numbers of risk genotypes.
Results
The study subjects included 210 fertile men and 467 infertile men with abnormal sperm analysis. The age and semen profiles of the subjects are shown in Table I . The characteristics of each category of infertile men are available in Supplementary data, Table SII. Six of our 'fertile' men had abnormal semen parameters: three had borderline oligozoospermia (sperm concentration 8 × 10 6 /ml, 16 × 10 6 /ml and 18 × 10 6 /ml, respectively), two had mild asthenozoospermia (motility 36 and 49%) and one had borderline teratozoospermia (normal form 27%). The concentration, motility and morphology of the sperm were significantly lower in the infertile group. The mean ages of fertile and infertile men were comparable. For all 17 markers, the minor allele frequencies were .0.05 (Table II) . Of the 17 polymorphic loci screened, four markers (rs228480 of ER-a, rs10046 CYP19A1, rs1799941 of SHBG and rs4680 of COMT) violated the HWE set at P , 0.05.
Single marker associations for semen parameters
The effect of each SNP on the semen parameters is summarized in Tables III, IV and V. Among the 17 tested genetic variants, sperm concentrations were significantly associated with a number of estrogenrelated genes in different genetic models, especially rs1801132(ER-a), rs2228480(ER-a), rs4986938(ER-b), rs1256049 (ER-b), rs605059 (HSD17B1), rs1799941 (SHBG), rs464903 (CYP1A1) and rs1048943 (CYP1A1) (Fig 1; Table III) . Of 17 polymorphisms we tested, five were significantly associated with sperm motility, including rs1801132 (ER-a), rs1256049(ER-b), rs605059 (HSD17B1), rs1799941 and rs6259 (SHBG) and rs1048943 (CYP1A1), especially in the dominant genetic model (Fig 1; Table IV ). None of these polymorphisms was significantly associated with sperm morphology (Table V) . The two deletion polymorphisms of GSTT1 and GSTM1 were not significantly associated with the parameters of semen analysis, based on the threshold set at P ¼ 0.01 (data not shown). Analysis of the first semen sample yielded very similar results (Supplementary data, Recruited from the male partners with abnormal semen parameters of the infertile couples who visited our specialist clinics. Estrogen-related genes and human semen
Multiple loci analysis
For the five loci which were significantly associated with lower sperm concentrations in the additive model, a joint analysis was performed. Both semen parameters (concentration and motility) tended to deteriorate with the increasing number of risk genotypes for associated markers ( Fig. 2A and B) . We also conducted 'test for trend' to evaluate whether semen parameters tend to deteriorate with increasing number of unfavorable genotypes. Using a mean t-test for 'continuous variables' for two sperm parameters to test for trend with increasing numbers of risk genotypes, the raw and 10 000 permutation test bootstrap P-values were ,0.0001 for the two sperm parameters of concentration and motility. These results indicated a polygenic model with dosage effects among associated loci for sperm concentration and motility.
Discussion
During the past decade, many case-control studies have shown an association of single or multiple estrogen-related genes with male infertility (Suzuki et al., 2002; Guarducci et al., 2006; Khattri et al., 2009; Lazaros et al., 2010) . Recently, we found that common polymorphisms of estrogen-related genes confer susceptibility to impaired sperm production (sperm counts ,2 × 10 6 /ml) at the prereceptor, receptor and post-receptor levels . Here, we went further to provide the first evidence that the estrogen-related pathway mainly affects sperm concentration and sperm motility. In the present study, a joint analysis based on an additive model was established to combine effects of multiple genes. We also conducted 'test for trend' with mean t-test to evaluate whether semen parameters tend to deteriorate with an increasing number of unfavorable genotypes. The unique point in the present study is to examine the associations between variants of estrogen-related genes and reproductive phenotypes more broadly (three semen parameters as quantitative traits). An additive model was applied to show cumulative genetic effects of multiple loci with a significant test for trend. This study demonstrates the power of quantitative trait analysis in dissecting genetic pathways which are associated with male infertility.
Considering the widespread expression of the ER and aromatase genes, the estrogenic effect in men might stem from both central and local actions. The balance between androgens and estrogens might be important at the multiple target sites, including central nervous system (Sharpe, 1998; Akingbemi, 2005) . Within the testis, all three types of cell (germ cell, Sertoli cell and Leydig cell) express ERs and aromatase, and are potential targets for both exogenous and endogenous estrogens (Tirado et al., 2004; Akingbemi, 2005; Mutembei et al., 2005; Cavaco et al., 2009) . Estrogens have been shown to play a role in the regulation of human germ cell survival in vitro (Pentikainen et al., 2000) . Adult monkeys treated with an aromatase inhibitor show maturation arrest of germ cells at the round spermatid stage, suggesting estrogen is important for germ cell differentiation (Shetty et al., 1997 (Shetty et al., , 1998 . In the seminiferous tubules of estrogen-deprived baboons, the Sertoli cells and germ cells were disorganized and the numbers were decreased (Albrecht et al., 2009) . It is possible that a Sertoli cell defect also accounts for maldevelopment of germ cells, considering the possible role of estrogens in Sertoli cell proliferation (Allan et al., 2010) . Collectively, estrogens may influence sperm concentration through directly affecting germ cell survival/differentiation and through inducing Sertoli cell dysfuntion (Petersen and Soder, 2006) .
Estrogens also influence sperm motility, directly or indirectly. Estradiol and aromatizable steroids were able to increase sperm motility and migration in vitro (Aquila et al., 2003 (Aquila et al., , 2004 . Recently, it was shown that a sperm motility defect in ERaKO mice may result from an abnormal epididymal milieu (Joseph et al., 2010 Estrogen-related genes and human semen re-absorption (Hess, 2000; Pentikainen et al., 2000; Shayu et al., 2005) . Estrogenic effects on spermatogenesis could also occur at different developmental stages. Inappropriately low or high exposure to estrogens during fetal, prepubertal and post-pubertal stages can disrupt spermatogenesis at different levels (hypothalamus, pituitary and testis) (Akingbemi, 2005; Delbes et al., 2006) . Studies have suggested that estrogens influence testicular development most notably during the fetal stage, a period of maximal testicular susceptibility to endocrine disruptors (Delbes et al., 2006; Boukari et al., 2007) . For example, estrogens could influence Leydig function through ERa mechanisms (Delbes et al., 2006; Cederroth et al., 2007) . Bisphenol was reported to induce alterations of the hypothalamic -pituitarygonadal axis in male rats exposed prenatally (Ramos et al., 2003) . In utero exposure to endocrine disruptors, such as dioxin, was shown to induce epididymal changes with decreased sperm counts (Foster et al., 2010) . However, these studies were largely based on rodents, and we should be extremely cautious to interpret rodent models considering a number of fundamental regulatory differences in testicular steroidogenesis between humans and rodents (Scott et al., 2009) .
The most frequent genetic alterations in infertile men are chromosomal rearrangements and Y chromosome micro-deletions. These two factors account for at least 10 -20% of cases with severe spermatogenic defects (Feng, 2003; Layman, 2003; de Llanos et al., 2005; Krausz and Degl'Innocenti, 2006; Gatta et al., 2010; Navarro-Costa et al., 2010) . Many Y-chromosomal and autosomal genes have been linked to impaired sperm production and/or decreased sperm count (Layman, 2003; Lee et al., 2008; Zuccarello et al., 2008) . Compared with genetic factors associated with impaired sperm production, relatively few genes have been reported to be implicated in poor sperm motility but genetic variants that were associated with low sperm motility included genes regulating mitochondria synthesis (St John et al., 2005) , such as the POLG gene which encodes the DNA polymerase gamma (Jensen et al., 2004; Harris et al., 2006) and mitochondrial haplotype T (Ruiz-Pesini et al., 2000) . Genetic variants of SRD5A2, which encodes type II 5 a-reductase, were associated with both sperm concentration and motility (Peters et al., 2010) . Recently, using quantitative trait analysis, we showed that genetic variants of DAZL may contribute to sperm count and motility . The present study adds estrogen-related genes to the list of genes interfering with sperm motility, a finding in concordance with the observations that some patients with aromatase deficiency presented with poor sperm motility (Simpson, 1998; Rochira et al., 2005; Carreau et al., 2006; Guarducci et al., 2006; Rochira and Carani, 2009) .
Environmental toxins have been implicated in male infertility (Oishi, 2002; Chen et al., 2008) . For example, genetic variants of dioxin receptor genes (e.g. AHR, AHRR and ARNT) and metabolism/detoxification genes (e.g. CYP1A1, GSTM1 and GSTT1) were associated with male infertility (Fritsche et al., 1998; Baccetti et al., 2005; Guarducci et al., 2006; Aydos et al., 2009; Finotti et al., 2009) . Endogenous estrogens are metabolized by CYP1A1, CYP1B1, CYP3A4 and COMT into hydroxy and methoxy estrogens, respectively (Hunter et al., 2005) . Xenobiotic substances could also be metabolized by the same group of enzymes and enter the pathway of estrogen functions (Fortunati et al., 2010) . In this study, we found that the null alleles of GSTM1 and GSTT1 were only marginally (P ¼ 0.05) associated with sperm count and motility, a finding in accordance with previous reports. Increasing the sample size in the future may help to clarify whether these two genes really play important roles in spermatogenic defects.
Teratozoospermia is a very heterogeneous condition composed of alterations in the shape of different sperm components (Chemes and Rawe, 2003) . Estrogens can also influence sperm morphology. In infertile men, the aromatase transcript amount has been shown to be negatively correlated with percentage of abnormal sperm (especially microcephaly and acrosome malformations) (Galeraud-Denis et al., 2009) . We tend to believe that decreasing amount of aromatase transcript (and enzyme activity) is not the primary cause of infertility. But, instead, may reflect systemic defects of abnormal spermatogenesis, considering the complex changes in transcriptome and proteomes in sperm with poor motility (Zhao et al., 2007; Martinez-Heredia et al., 2008; Garcia-Herero et al., 2010) . It has been shown that sperm recovered from epididymis of ERaKO mice exhibited flagellar Figure 1 The distribution of sperm parameters in groups of different genotypes at the significant genetic loci tested.
abnormalities and the anomalies of sperm are a consequence of an abnormal luminal environment (Joseph et al., 2010) . Given only partial functional impairment of estrogen-related pathways, we speculate the luminal dysfunction was not severe enough to cause morphological anomalies of sperm.
Several SNPs deviated from HWE, and these were not exclusively a result of genotyping error. The violation could also be linked to heterozygous advantage, population admixture/substructure, inbreeding, copy number variants or chance (Li and Leal, 2009 ). Because the accuracy of the genotypes was double-checked in this study, we decided not to exclude these markers from analysis, considering that genotypes with adverse effects on reproduction may deviate from HWE (Li and Li, 2008; Minelli et al., 2008) . It is also intriguing that two minor alleles were correlated with increased, instead of decreased sperm count (SNP rs2228480 of ER-a and SNP rs4986938 of ER-b) and of interest that rs2228480 also violated HWE. Similar situations also occurred with some SNPs (e.g. rs6068020 and rs10841496) in a genome-wide study for azoospermia and severe oligozoospermia (Aston and Carrell, 2009 ). The minor alleles usually indicated dysfunction of genes associated with the pathological condition or phenotype. There are two explanations for the paradox. First, the genetic markers genotyped may not be actual functional variants. It is possible that the genetic marker resides within linkage disequilibrium (LD) blocks with real functional significance. Tissue-or cell-specificity also exists for genetic variants (Dimas et al., 2009; Sun et al., 2010) , causing genetic or allelic heterogeneity. The possibility that a genetic variant is beneficial for some cell types while harmful for other cell types could not be completely excluded. Considering the varied expression levels of estrogen-related genes in different tissues, the rule of general dysfunction may not be universally applicable.
Traditionally, a simple genetic model (dominant, recessive or co-dominant model) is used to test the association between genetic variants and common diseases. In this study, all three models were applied to analyze the raw data, as most common diseases could not be explained by a simple genetic model (Ritchie et al., 2001; Cho et al., 2004; Williams et al., 2004) . Our finding suggests that estrogen-related genes are mainly involved in regulating sperm concentration and sperm motility. This finding is consistent with a previous study in which the authors suggested that idiopathic oligoasthenoteratozoospermia may occur by means of two independent pathways, the first affecting concentration and/or motility and the second affecting morphology (Cavallini et al., 2008) .
There were some limitations in the current study. Some SNPs are located within introns or untranslated regions. These SNPs may affect splicing, gene expression level or be in LD with other functional SNPs (Baralle and Baralle, 2005; Wang and Cooper, 2007; Wray, 2007) . Some SNPs are synonymous substitutions, which could alter splicing or translational efficiency (Nackley et al., 2006 (Nackley et al., , 2009 Wang and Cooper, 2007) . Even without direct functional consequences, synonymous substitutions could also influence gene function through LD with other SNPs. Although some tagSNPs were selected for genotyping, only one to three SNPs were genotyped for each gene, and these markers may not provide full coverage for genetic tests. Among the estrogen-metabolizing enzymes, we chose two genes in the phase I metabolic pathway (CYP1A1 and CYP1B1) and three genes (GSTM1, GSTT1 and COMT) in the phase II pathway only. Notwithstanding these limitations, this study still provides a representative gene panel to evaluate the estrogenic effect.
In conclusion, our finding suggests that the pathways regulating sperm motility and count are intertwined and are co-regulated by estrogen-related genes. As compared with case -control association studies, quantitative trait analysis may provide a more comprehensive approach for exploring the association between candidate genetic markers and spermatogenesis, given an adequate sample size and that all participants are well characterized. Using a mean t-test for 'continuous variables' for two sperm parameters to test for trend with increasing numbers of risk genotypes, the raw and 10 000 permutation test bootstrap P-values were ,0.0001 for the two sperm parameters of concentration and motility. These results indicated a polygenic model with dosage effects among associated loci for sperm concentration and motility.
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